Recently, it was suggested that serum concentration of both MCP-1 and TGF-beta were suppressed by administration of 9×105 units of ulinastatin in patients with connective tissue disease associated pulmonary fibrosis [14], [15]. This evidence concerns the gene CCL2 and connective tissue disorder.